- Meeting abstract
- Open Access
118 Manganese guided cellular MRI enables evaluation of human stromal cell viability
© Yamada et al; licensee BioMed Central Ltd. 2008
- Published: 22 October 2008
- Spin Echo
- Spin Echo Sequence
- Manganese Chloride
- Inversion Recovery Sequence
Human stromal cells (hSC) have demonstrated restorative capabilities of the injured myocardium. Although iron oxide particles have demonstrated in vivo MRI cell tracking, fundamental biological properties including cell viability of transplanted cells are not evaluated. We tested the hypothesis that manganese chloride (MnCl2) will enable MRI assessment of hSC viability.
Human stromal cells (Cognate, Sunnyvale, CA) were trypsinized and labeled with different concentrations of MnCl2 in normal saline and incubated for 0.5–1.0 hour at 37°C and 5% CO2. Biological properties of hSC were monitored by modulating the activity of calcium channels using verapamil (calcium channel antagonist). T1 and T2 mapping was performed at 0.01–3.00 mM of MnCl2 solution with 1.5 T GE Excite whole-body MRI scanner (Signa, GE Medical Systems, Milwaukee, WI) with a 5-inch receive only surface coil. For T1 measurements, spin echo (SE) inversion recovery sequence (FOV 12 cm, matrix size of 128 × 128, TR 3000 ms and TE 50–2200 ms at 300 ms steps) were used. We made T2 measurements using SE sequence (FOV 12 cm, matrix size of 128 × 128, TR 2500 ms and TE 10–80 ms at 10 ms steps). Then the data were analyzed to extract T1 and T2 values through nonlinear least-square fits to the SE inversion recovery and the SE decay curve respectively. In vitro cellular MRI was performed using optimized SE sequence (FOV 12 cm, matrix size of 256 × 256, TR 800 ms and TE 3.4 ms). Modulation of hSC calcium channel activity by verapamil was assessed by measuring changes in signal intensity.
MnCl2-guided cellular MRI demonstrates the potential to detect calcium-channel mediated biology of transplanted hSC including cell viability. This technique may enable MRI-guided biological evaluation of transplanted cells.
This article is published under license to BioMed Central Ltd.